13F Insight

Daniel Mark James

CIK: 0002092593•Chief Financial Officer
Officer
Primary company: ATOSSA THERAPEUTICS, INC. (ATOS)

Daniel Mark James is a corporate insider (Chief Financial Officer) at ATOSSA THERAPEUTICS, INC. (ATOS) filing SEC Form 4 transactions. 2 transactions. Source: SEC EDGAR.

Total Transactions
2
Total Buy Value
$0
Total Sell Value
$0
Net Activity
$0
Last Transaction
Mar 2026
Companies
1

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
63,000
Price
-
Value
-
Type
Award
Shares
578,000
Price
-
Value
-